dc.creatorKloc, Malgorzata
dc.creatorGhobrial, Rafik M.
dc.creatorKuchar, Ernest
dc.creatorLewick, Slawomir
dc.date.accessioned2020-07-31T19:26:12Z
dc.date.accessioned2022-09-23T18:35:47Z
dc.date.available2020-07-31T19:26:12Z
dc.date.available2022-09-23T18:35:47Z
dc.date.created2020-07-31T19:26:12Z
dc.identifier1521-6616
dc.identifierhttps://doi.org/10.1016/j.clim.2020.108510
dc.identifierhttp://hdl.handle.net/20.500.12010/11481
dc.identifierhttps://doi.org/10.1016/j.clim.2020.108510
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3503825
dc.description.abstractChildren, because of having an immature immune system, are usually more prone than the adults to the microbial infections and have more severe symptoms, which is especially true for the newborns, and very young children. However, the review of clinical data from the current COVID-19 pandemic indicates otherwise. We discuss here what are the main features and components of children's immune system, the role of maternal transmission of immunity, and what are the possible explanations for the seemingly lower infection rate and severity of COVI-19 in children.
dc.publisherImmunotherapy for neurological diseases
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectChild immunity
dc.subjectCOVID-19
dc.subjectImmune system development
dc.subjectMacrophages
dc.titleDevelopment of child immunity in the context of COVID-19 pandemic


Este ítem pertenece a la siguiente institución